186 related articles for article (PubMed ID: 31418082)
1. Dabrafenib in BRAFV600E mutant pilocytic astrocytoma in a pediatric patient.
Mustansir F; Mushtaq N; Darbar A
Childs Nerv Syst; 2020 Jan; 36(1):203-207. PubMed ID: 31418082
[TBL] [Abstract][Full Text] [Related]
2. Dabrafenib for Pilocytic Astrocytoma With
Tanaka R; Mrachek K; Arocho-Quinones E; Carlberg VM; Smith C; Kurzrock R; Deshmukh T
JCO Precis Oncol; 2024 May; 8():e2400055. PubMed ID: 38781546
[TBL] [Abstract][Full Text] [Related]
3. Dabrafenib in BRAFV600-mutated anaplastic pleomorphic xanthoastrocytoma.
Brown NF; Carter T; Mulholland P
CNS Oncol; 2017 Jan; 6(1):5-9. PubMed ID: 27781490
[TBL] [Abstract][Full Text] [Related]
4. Challenges of targeting
Smith-Cohn M; Davidson C; Colman H; Cohen AL
CNS Oncol; 2019 Dec; 8(4):CNS48. PubMed ID: 31818130
[No Abstract] [Full Text] [Related]
5. Dabrafenib and trametinib in BRAFV600E mutated glioma.
Brown NF; Carter T; Kitchen N; Mulholland P
CNS Oncol; 2017 Oct; 6(4):291-296. PubMed ID: 28984141
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Dabrafenib for three children with brainstem BRAF
Philippe L; Maria K; Tariq A; Sofia M; Christine SM; Jean-Pierre F; Dudley RW; Sébastien P; Nada J; Valérie L
J Neurooncol; 2019 Oct; 145(1):135-141. PubMed ID: 31502039
[TBL] [Abstract][Full Text] [Related]
7. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G
Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545
[TBL] [Abstract][Full Text] [Related]
8. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.
Kurani H; Gurav M; Shetty O; Chinnaswamy G; Moiyadi A; Gupta T; Jalali R; Epari S
Childs Nerv Syst; 2019 Sep; 35(9):1525-1536. PubMed ID: 31321520
[TBL] [Abstract][Full Text] [Related]
9. Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report.
Casadevall D; Vidal J; Gallardo F; Zuccarino F; Arumí-Uría M; Dalmases A; Bellosillo B; Montagut C
J Med Case Rep; 2016 Jun; 10(1):158. PubMed ID: 27255157
[TBL] [Abstract][Full Text] [Related]
10. Pilocytic astrocytoma in adults: Histopathological, immunohistochemical and molecular study with clinical association.
Salles D; Santino SF; Diana P; Malinverni ACM; Stávale JN
Pathol Res Pract; 2023 Dec; 252():154942. PubMed ID: 37984046
[TBL] [Abstract][Full Text] [Related]
11. Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma.
Balasubramanian A; Gunjur A; Gan HK; Perchyonok Y; Cher LM
J Clin Neurosci; 2020 Sep; 79():269-271. PubMed ID: 33070910
[TBL] [Abstract][Full Text] [Related]
12. Recurrent ganglioglioma in adults treated with BRAF inhibitors.
Chamberlain MC
CNS Oncol; 2016; 5(1):27-9. PubMed ID: 26680369
[TBL] [Abstract][Full Text] [Related]
13. Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor.
Grenier-Chartrand F; Barrit S; Racu ML; Luce S; Spitaels J; Sadeghi-Meibodi N; Lebrun L; Salmon I; Lefranc F; De Witte O
Acta Neurochir (Wien); 2022 Mar; 164(3):737-742. PubMed ID: 35029761
[TBL] [Abstract][Full Text] [Related]
14. Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib.
Usubalieva A; Pierson CR; Kavran CA; Huntoon K; Kryvenko ON; Mayer TG; Zhao W; Rock J; Ammirati M; Puduvalli VK; Lehman NL
J Neuropathol Exp Neurol; 2015 Oct; 74(10):960-9. PubMed ID: 26352988
[TBL] [Abstract][Full Text] [Related]
15. Dabrafenib in BRAFV600E mutant pilocytic astrocytoma.
Yasri S; Wiwanitkit V
Childs Nerv Syst; 2020 May; 36(5):893. PubMed ID: 32002607
[No Abstract] [Full Text] [Related]
16. The involvement of the MAPK pathway in pilocytic astrocytomas.
Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
[TBL] [Abstract][Full Text] [Related]
17. Dabrafenib Effective in Pediatric Glioma.
Cancer Discov; 2017 Jan; 7(1):OF5. PubMed ID: 28062673
[TBL] [Abstract][Full Text] [Related]
18. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
19. Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma.
Menzies AM; Long GV
Clin Cancer Res; 2014 Apr; 20(8):2035-43. PubMed ID: 24583796
[TBL] [Abstract][Full Text] [Related]
20. Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring.
Pasqualetti F; Restante G; Gonnelli A; Rofi E; Molinari A; Crucitta S; Paiar F; Rudà R; Danesi R; Soffietti R; Del Re M
Neuro Oncol; 2019 Dec; 21(12):1610-1611. PubMed ID: 31504796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
